148 related articles for article (PubMed ID: 7107047)
1. Secondary hyperoxalemia in chronic renal failure.
Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
Int J Artif Organs; 1982 May; 5(3):141-3. PubMed ID: 7107047
[No Abstract] [Full Text] [Related]
2. Myocardial calcinosis associated with hemodialysis.
Zazgornik J; Balcke P; Biesenbach G; Kaiser W; Stockenhuber F
Am J Cardiol; 1987 Aug; 60(4):421-2. PubMed ID: 3618514
[No Abstract] [Full Text] [Related]
3. [Secondary oxalosis in chronic renal insufficiency].
Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
Z Urol Nephrol; 1982 Jun; 75(6):409-14. PubMed ID: 7124142
[TBL] [Abstract][Full Text] [Related]
4. Effect of vitamin B6 administration on elevated plasma oxalic acid levels in haemodialysed patients.
Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
Eur J Clin Invest; 1982 Dec; 12(6):481-3. PubMed ID: 6818036
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin B6 supplementation on plasma oxalate and oxalate removal rate in hemodialysis patients.
Costello JF; Sadovnic MC; Smith M; Stolarski C
J Am Soc Nephrol; 1992 Oct; 3(4):1018-24. PubMed ID: 1450364
[TBL] [Abstract][Full Text] [Related]
6. Reduction of elevated plasma oxalic acid by pyridoxine therapy in patients on RDT.
Balcke P; Schmidt P; Zazgornik J; Kopsa H
Proc Eur Dial Transplant Assoc; 1983; 19():308-12. PubMed ID: 6878246
[TBL] [Abstract][Full Text] [Related]
7. Hyperoxalemia in renal failure and the role of hemoperfusion and hemodialysis in primary oxalosis.
Ahmad S; Hatch M
Nephron; 1985; 41(3):235-40. PubMed ID: 4058624
[TBL] [Abstract][Full Text] [Related]
8. Serum oxalate in chronic renal failure.
Borland WW; Payton CD; Simpson K; Macdougall AI
Nephron; 1987; 45(2):119-21. PubMed ID: 3561621
[TBL] [Abstract][Full Text] [Related]
9. Effect of pyridoxine supplementation on plasma oxalate concentrations in patients receiving dialysis.
Tomson CR; Channon SM; Parkinson IS; Sheldon WS; Ward MK; Laker MK
Eur J Clin Invest; 1989 Apr; 19(2):201-5. PubMed ID: 2499479
[TBL] [Abstract][Full Text] [Related]
10. Ascorbic acid aggravates secondary hyperoxalemia in patients on chronic hemodialysis.
Balcke P; Schmidt P; Zazgornik J; Kopsa H; Haubenstock A
Ann Intern Med; 1984 Sep; 101(3):344-5. PubMed ID: 6465702
[No Abstract] [Full Text] [Related]
11. [Oxalic acid metabolism in chronic renal failure].
Balcke P
Wien Klin Wochenschr Suppl; 1985; 160():1-15. PubMed ID: 3859955
[TBL] [Abstract][Full Text] [Related]
12. [Hyperoxalemia and secondary oxalosis of chronic renal insufficiency].
Schillinger F; Montagnac R; Milcent T
Nephrologie; 1990; 11(4):211-5. PubMed ID: 2074920
[No Abstract] [Full Text] [Related]
13. Renal replacement therapy and secondary hyperoxalemia in chronic renal failure.
Mydlík M; Derzsiová K
Kidney Int Suppl; 2001 Feb; 78():S304-7. PubMed ID: 11169031
[TBL] [Abstract][Full Text] [Related]
14. Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients.
Ono K
Clin Nephrol; 1986 Nov; 26(5):239-43. PubMed ID: 3802587
[TBL] [Abstract][Full Text] [Related]
15. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients.
Pru C; Eaton J; Kjellstrand C
Nephron; 1985; 39(2):112-6. PubMed ID: 3974772
[TBL] [Abstract][Full Text] [Related]
16. Primary hyperoxaluria: therapeutic strategies for the 90's.
Scheinman JI
Kidney Int; 1991 Sep; 40(3):389-99. PubMed ID: 1787639
[No Abstract] [Full Text] [Related]
17. Secondary oxalosis in chronic renal insufficiency.
Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
N Engl J Med; 1980 Oct; 303(16):944. PubMed ID: 7412832
[No Abstract] [Full Text] [Related]
18. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.
Kasidas GP; Rose GA
Clin Chim Acta; 1986 Jan; 154(1):49-58. PubMed ID: 3943224
[TBL] [Abstract][Full Text] [Related]
19. Oxalate depuration during biofiltration with AN69 and in conventional hemodialysis in chronic renal failure (CRF) patients.
Chimienti S; Mele G; Perrone F; Muscogiuri P; Cristofano C
Int J Artif Organs; 1986 Dec; 9 Suppl 3():73-4. PubMed ID: 3557678
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
